Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-167319
Filing Date
2022-06-03
Accepted
2022-06-03 16:12:38
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d361240ds3.htm S-3 400027
2 EX-1.2 d361240dex12.htm EX-1.2 171325
3 EX-4.3 d361240dex43.htm EX-4.3 296867
4 EX-4.6 d361240dex46.htm EX-4.6 97022
5 EX-4.7 d361240dex47.htm EX-4.7 98401
6 EX-4.8 d361240dex48.htm EX-4.8 86533
7 EX-5.1 d361240dex51.htm EX-5.1 30823
8 EX-23.1 d361240dex231.htm EX-23.1 1262
9 EX-FILING FEES d361240dexfilingfees.htm EX-FILING FEES 42754
10 GRAPHIC g361240dsp001.jpg GRAPHIC 3065
11 GRAPHIC g361240g40t28.jpg GRAPHIC 50143
  Complete submission text file 0001193125-22-167319.txt   1295254
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265408 | Film No.: 22994503
SIC: 2834 Pharmaceutical Preparations